The TransMed7 team was most delighted to initiate the “soft” launch of its primary breast platform devices, SpeedBirdTM and ConcordeTM including SpeedBird 38, SpeedBird Universal, and SpeedBird Universal 99 as well as Concorde Stereotactic (ST) and Concorde Ultrasound (US) at the recent American Society of Breast Surgeons (ASBrS) meeting in Dallas. Over the last several months, the TransMed7 team has been very hard at work preparing to bring our novel platforms to clinicians and patients in need. In that regard, we were pleased to demonstrate the substantial evolution which has occurred with SpeedBIrd and Concorde and continues with additional new devices for breast health including VacuPacTM, a portable external vacuum assist device, CardinalTM, a fine-needle core biopsy device, and MartinetTM, a total lesion excisional device. Each of these proprietary, next generation breast biopsy devices combine innovative technology with cost efficient manufacturing, which results in easy to use, affordable platform devices that address the worldwide market.
The TransMed7 team was most delighted to initiate the “soft” launch of its primary breast platform devices, SpeedBirdTM and ConcordeTM including SpeedBird 38, SpeedBird Universal, and SpeedBird Universal 99 as well as Concorde Stereotactic (ST) and Concorde Ultrasound (US) at the recent American Society of Breast Surgeons (ASBrS) meeting in Dallas. Over the last several months, the TransMed7 team has been very hard at work preparing to bring our novel platforms to clinicians and patients in need. In that regard, we were pleased to demonstrate the substantial evolution which has occurred with SpeedBIrd and Concorde and continues with additional new devices for breast health including VacuPacTM, a portable external vacuum assist device, CardinalTM, a fine-needle core biopsy device, and MartinetTM, a total lesion excisional device. Each of these proprietary, next generation breast biopsy devices combine innovative technology with cost efficient manufacturing, which results in easy to use, affordable platform devices that address the worldwide market.
SpeedBird 38 is characterized by fully automated cycling (tissue coring, part-off, and transport), vacuum assistance, a built-in power supply, 12- and 14-gauge working elements, and a radiolucent tissue magazine which may contain fixative. Like SpeedBird 38, SpeedBird Universal is characterized by vacuum assistance, a built-in power supply, 12- and 14-gauge working elements, and a radiolucent tissue magazine which may contain fixative, but with manual cycling; in addition, SpeedBird Universal 99 has a reusable handle and replaceable needles.
Similar to the SpeedBird device platform, the Concorde is also based on TransMed7’s patented, proven, Zero5TM technology, comprising a fused, single element forming its multifunctional tip. This single element tip is capable of cycling between configurations so as to perform an ideal biopsy procedure under various guidance modalities. In the case of the Concorde devices the multifunctional tip also includes the addition of an outer guiding and anchoring shield or scoopula. The Concorde devices are designed for use in conjunction with stereotactic and 2D/3D tomosynthesis (Concorde ST) and ultrasound (Concorde US) guidance. Because of their unique design, the Concorde devices are fully automated, forward and side coring, vacuum-assisted, single insertion/multiple-sample (SIMS) devices with built-in power supply (console-less), 12- or 14-gauge working element, and a radiolucent tissue magazine which may contain fixative. All of Concorde US’s functions are provided within a single-use handle design that obviates the need for an expensive console driver and which simplifies the set-up, specimen acquisition, and storage procedure. In its letter-to-file, TransMed7 documented how Concorde ST’s housing is enhanced for placement on a stereotactic or 2D/3D biopsy gantry, including the provision to activate an automatic partial cycle pause and full-cycle resumption, further simplifying image correlation documentation of post-core needle position, as well as a remote control for operator comfort and convenience.
Without requiring a sharp needle tip to advance through tissue or the need to first fire a sharp tip through or past the target lesion, the SpeedBird and Concorde needle tips can, with minimal disruption, approach, core, sever, and transport multiple samples of a target lesion via a closed-circuit flush and vacuum mechanism into TransMed7’s detachable, proprietary, tissue preservation and transport chamber.
